Ohio State Navbar

News


Dr. Dungan published data from clinical study in Lancet


July 30, 2014

Dr. Dungan published data from clinical study to compare dose schedule of dulaglutide and liraglutide (glucagon-like peptide-1 receptor agonists). The rest of the story



SPORE GRANT WILL BOOST THYROID CANCER RESEARCH


November 06, 2013

SPORE GRANT WILL BOOST THYROID CANCER RESEARCH The rest of the story



NCI Renews Support for Major Thyroid-Cancer Research Effort at Ohio State


September 06, 2013

NCI Renews Support for Major Thyroid-Cancer Research Effort at Ohio State The rest of the story